<DOC>
	<DOCNO>NCT01941199</DOCNO>
	<brief_summary>This randomize , open-label , multiple dosing , three-way crossover clinical trial investigate pharmacokinetic/pharmacodynamic drug-drug interaction DA-1229 5 mg Metformin IR 1000 mg oral administration healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic/Pharmacodynamic Drug-drug Interaction DA-1229 Metformin After Oral Administration Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 20 45 , healthy male subject ( screen ) Body weight 55kg 90kg , BMI 18.0 27.0 FPG 70125mg/dL glucose level ( screen ) Subject totally understand progress clinical trial , make decision free , signed consent form follow progress . Subject past present history disease follow . ( liver include hepatitis virus carrier , kidney , Neurology , immunology , pulmonary , endocrine , hematooncology , cardiology , mental disorder ) Subject GI tract disease ( Crohn 's disease , ulcer , acute chronic pancreatitis ) surgery ( appendectomy , hernioplasty exclude ) Subject drug ( Aspirin , antibiotic ) hypersensitivity reaction Subject already participate trial 2 month Subject whole blood donation 2 month , component blood donation 1 month transfusion 1 month currently .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>